Instil Bio, Inc. (TIL) stock
TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.24−0.07 (-1.11%)
Close on Nov 12, 2026Market cap $42.32MP/E –Yield –
Instil Bio cash
Cash and short-term investments held at the end of each period.
Instil Bio's cash was $5.54M at Jun 30, 2026. For fiscal 2025 it was $6.64M, down 37.6% from the year before. The highest annual figure on record is $454.60M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.64M | -37.6% |
| FY2024 | Dec 31, 2024 | $10.64M | -93.0% |
| FY2023 | Dec 31, 2023 | $151.86M | -41.8% |
| FY2022 | Dec 31, 2022 | $260.92M | -42.6% |
| FY2021 | Dec 31, 2021 | $454.60M | +88.0% |
| FY2020 | Dec 31, 2020 | $241.76M | +2618.0% |
| FY2019 | Dec 31, 2019 | $8.90M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.54M | -29.3% |
| Q1 FY2026 | Mar 31, 2026 | $5.02M | -69.2% |
| Q4 FY2025 | Dec 31, 2025 | $6.64M | -37.6% |
| Q3 FY2025 | Sep 30, 2025 | $5.80M | -12.9% |
| Q2 FY2025 | Jun 30, 2025 | $7.84M | +15.6% |
| Q1 FY2025 | Mar 31, 2025 | $16.33M | +197.7% |
| Q4 FY2024 | Dec 31, 2024 | $10.64M | -93.0% |
| Q3 FY2024 | Sep 30, 2024 | $6.66M | -96.4% |
| Q2 FY2024 | Jun 30, 2024 | $6.78M | -96.7% |
| Q1 FY2024 | Mar 31, 2024 | $5.48M | -97.6% |
| Q4 FY2023 | Dec 31, 2023 | $151.86M | -41.8% |
| Q3 FY2023 | Sep 30, 2023 | $184.46M | -39.3% |
| Q2 FY2023 | Jun 30, 2023 | $202.86M | -42.9% |
| Q1 FY2023 | Mar 31, 2023 | $223.87M | -41.1% |
| Q4 FY2022 | Dec 31, 2022 | $260.92M | -42.6% |
| Q3 FY2022 | Sep 30, 2022 | $303.79M | -41.1% |
| Q2 FY2022 | Jun 30, 2022 | $355.11M | -37.3% |
| Q1 FY2022 | Mar 31, 2022 | $380.02M | -37.7% |
| Q4 FY2021 | Dec 31, 2021 | $454.60M | +88.0% |
| Q3 FY2021 | Sep 30, 2021 | $515.86M | +202.2% |
| Q2 FY2021 | Jun 30, 2021 | $566.78M | +211.7% |
| Q1 FY2021 | Mar 31, 2021 | $609.69M | +10773.7% |
| Q4 FY2020 | Dec 31, 2020 | $241.76M | +2618.0% |
| Q3 FY2020 | Sep 30, 2020 | $170.68M | – |
| Q2 FY2020 | Jun 30, 2020 | $181.85M | – |
| Q1 FY2020 | Mar 31, 2020 | $5.61M | – |
| Q4 FY2019 | Dec 31, 2019 | $8.90M | – |
See a number that looks wrong?